logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

ZHIHU-W (02390) spent approximately US$103,200 to repurchase approximately 97,100 shares on September 21.

date
20:00 22/09/2026
avatar
GMT Eight
ZHIHU-W (02390) announced that on September 21, 2026, the company spent approximately US$103,200 to repurchase approximately 97,100 shares at a repurchase price of US$1.0433 to US$1.1 per share.
ZHIHU-W (02390) announced that on September 21, 2026, the company spent approximately US$103,200 to repurchase approximately 97,100 shares at a repurchase price of US$1.0433 to US$1.1 per share.
Related Articles
China Stock
Genimous Technology (000676.SZ) plans to launch a 2026 restricted stock incentive plan.
US Stock
Viking Therapeutics (VKTX.US) Weight-Loss Drug Delivers Good News: Halving Dosing Frequency Still Maintains 97% Weight Loss, Stock Price Once Soared Nearly 50% in Pre-Market Trading
China Stock
Dongguan Development (000828.SZ) subsidiary plans to invest 75 million yuan in Tongzhi Fund.
Genimous Technology (000676.SZ) plans to launch a 2026 restricted stock incentive plan.
China Stock
Viking Therapeutics (VKTX.US) Weight-Loss Drug Delivers Good News: Halving Dosing Frequency Still Maintains 97% Weight Loss, Stock Price Once Soared Nearly 50% in Pre-Market Trading
US Stock
Dongguan Development (000828.SZ) subsidiary plans to invest 75 million yuan in Tongzhi Fund.
China Stock
RECOMMEND
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.